Drug lookup
Drug reference

pyrantel pamoate

Tetrahydropyrimidine analogue · Anthelmintic

Tetrahydropyrimidine analogueAnthelmintic
CDSCO approved
EXCRETION
not curated
INTERACTIONS
1 major
incl. contraindicated
PREGNANCY
not curated
Top interactions
  • PiperazineContraindicatedTextbookHarrison 22e · p1751

Mechanism

Pyrantel pamoate is a depolarizing neuromuscular blocking agent. It opens nonselective cation channels and induces persistent activation of nicotinic acetylcholine receptors, specifically the L type, leading to spastic paralysis of the worm. It also inhibits cholinesterases.

Indications

ascariasisenterobiasishookworm infections caused by A. duodenale and N. americanusmixed infections with T. trichiurapinworm infectionsPin worm (Enterobius)Roundworm (Ascaris)Hookworm (Ancylostoma, Necator)

Dosing

Adult
Ascaris, Ancylostoma and Enterobius: single dose of 10 mg/kg. Necator and for Strongyloides: a 3 day course has been suggested.

Pharmacokinetics

Bioavailability
Only 10–15% of an oral dose is absorbed.
Metabolism
Poorly absorbed from the GI tract.
Excretion
Less than 15% excreted in urine as parent drug and metabolites; major proportion recovered in feces.

Contraindications

  • Safety in pregnant women not established
  • Safety in children below 2 years not established

Side effects

Common
transient GI symptomsheadachedizzinessrashfeverG.i. symptoms (occasional)

Drug interactions

Piperazine
Contraindicated
Textbook

Antagonistic effect, reducing efficacy.

Should not be used concomitantly.

Source: Harrison 22e · p1751

Related guidelines

Other Tetrahydropyrimidine analogue drugs

Ask House about pyrantel pamoate

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team